Women with an inherited BRCA1 mutation have an increased risk of breast and ovarian cancer. This type of tumour depends on the protein EXO1 to survive. Thanks to a KWF grant, Sebastian Pomplun, together with geneticist Sylvie Noordermeer, is investigating new inhibitors to disable this protein.
Leiden researchers receive over €1 million for research into BRCA1 cancer treatment
calendar_today
August 12, 2026
domain
leiden